Long-Term Follow-up Safety of Clonidine Micropellets
| Status: | Enrolling by invitation |
|---|---|
| Conditions: | Neurology |
| Therapuetic Areas: | Neurology |
| Healthy: | No |
| Age Range: | 18 - 70 |
| Updated: | 1/17/2019 |
| Start Date: | November 15, 2018 |
| End Date: | May 2019 |
A Multicenter, Randomized, Follow-up Study to Evaluate the Long-Term Safety of Clonidine Micropellets for the Treatment of Pain Associated With Lumbosacral Radiculopathy in Adults
Long-term follow-up study to evaluate the safety of clonidine micropellets up to 12 months
post injection.
post injection.
Inclusion Criteria:
- Subject who have successfully completed all STX-015-18-01 study related activities,
are reconfirmed to be eligible and have signed informed consent to participate.
Exclusion Criteria:
- Subjects who, in the opinion of the investigator, have demonstrated significant
non-compliance with STX-015-18-01 study procedures.
- Subjects who were unblinded to their treatment in STX-015-18-01 study.
We found this trial at
7
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials